Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data - Concepedia

Concepedia

Publication | Open Access

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

DOI Full Paper Access

18

Citations

24

References

2019

Year

María Fernanda Guerra Veloz, María Belvis Jiménez, Teresa Valdés Delgado, Luisa Castro Laria, Belén Maldonado Pérez, Raúl Perea Amarillo, Vicente Merino Bohórquez, Ángel Caunedo Álvarez, Ángel Vilches‐Arenas, Federico Argüelles‐Arias

Therapeutic Advances in Gastroenterology

Abstract

Most of the patients switching from original infliximab were maintained on CT-P13 at 2 years of follow up with a good profile of efficacy and safety.

References

	Year	Citations

Page 1